We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

276 hedge funds and large institutions have $520M invested in Avanos Medical in 2025 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 72

0.25% more ownership

Funds ownership: 96.72% → 96.97% (+0.25%)

3% less funds holding

Funds holding: 286 → 276 (-10)

5% less capital invested

Capital invested by funds: $548M → $520M (-$27.7M)

15% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 48

Holders
276
Holders Change
-10
Holders Change %
-3.5%
% of All Funds
3.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
92
Reduced
72
Closed
48
Calls
$449K
Puts
–
Net Calls
+$449K
Net Calls Change
+$722K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$8.4M
2
Millennium Management
Millennium Management
New York
+$7.95M
3
AC
Armistice Capital
New York
+$5.43M
4
Ameriprise
Ameriprise
Minnesota
+$5.41M
5
Brown Advisory
Brown Advisory
Maryland
+$4.89M

Top Sellers

Rank Fund Capital Flow
1
PIM
Paradice Investment Management
Colorado
-$15.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$12.2M
3
ECM
ExodusPoint Capital Management
New York
-$10.3M
4
TCM
Tributary Capital Management
Nebraska
-$9.92M
5
JGC
J. Goldman & Co
New York
-$5.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
226
Addison Advisors
Vermont
$578 – – –
AIC
227
Archer Investment Corporation
Indiana
$578 – – –
HFS
228
Hughes Financial Services
Virginia
$549 +$562 +48 New
BFS
229
Bare Financial Services
Pennsylvania
$474 +$480 +41 New
MCM
230
MV Capital Management
Maryland
$463 – – –
PSB
231
Piscataqua Savings Bank
New Hampshire
$462 – – –
AAS
232
Ameritas Advisory Services
Nebraska
$428 -$3.54K -302 -89%
FC
233
Financial Consulate
Maryland
$417 +$422 +36 New
FMII
234
Farmers & Merchants Investments Inc
Nebraska
$416 – – –
BSB
235
Bangor Savings Bank
Maine
$358 – – –
CAC
236
Core Alternative Capital
Georgia
$347 – – –
HIA
237
Harbor Investment Advisory
Maryland
$347 – – –
Rockefeller Capital Management
238
Rockefeller Capital Management
New York
$301 +$304 +26 New
BC
239
Broadwater Capital
Massachusetts
$289 -$3.29K -281 -92%
AF
240
Advisornet Financial
Minnesota
$289 – – –
DWM
241
Darwin Wealth Management
Florida
$289 – – –
SS
242
Sunbelt Securities
Texas
$289 +$293 +25 New
WT
243
Whittier Trust
California
$283 -$105 -9 -27%
WTC
244
WhitTier Trust Company
Nevada
$282 – – –
WBWA
245
William B. Walkup & Associates
South Carolina
$266 – – –
CA
246
CoreCap Advisors
Michigan
$231 – – –
ASN
247
Advisory Services Network
Georgia
$223 +$223 +19 New
CSB
248
City State Bank
Iowa
$208 – – –
National Bank of Canada
249
National Bank of Canada
Quebec, Canada
$204 +$211 +18 New
T
250
Tidemark
California
$197 – – –
8 9
10
11 12

AVNS Hedge Fund Activity: Q3 2025 in Review

276 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2025, worth a combined $520M — down 5% from $548M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of AVNS and 41 opened new positions — a net loss of 7 holders — while 72 trimmed existing stakes and 92 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $8.4M. The largest seller was Paradice Investment Management, exiting entirely with an estimated $15.4M sold.

  • 276 institutional investors held Avanos Medical (AVNS) as of Q3 2025, down from 286 in Q2 2025.
  • Funds reported $520M of Avanos Medical stock for Q3 2025, down 5% quarter-over-quarter.
  • 41 funds opened new Avanos Medical positions in Q3 2025 and 48 closed out, a net change of -7 holders.
  • The largest Avanos Medical buyer in Q3 2025 was T. Rowe Price Investment Management, an estimated $8.4M added.
  • The largest Avanos Medical seller in Q3 2025 was Paradice Investment Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2025.